InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Lurker Nancy, Chairman & CEO. Director active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 10 disclosures have been logged. Total volume traded: €628k. The latest transaction was filed on 13 May 2026 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€138,1534,500 shares@ €30.70070.0094% mcap100.0% of flow
Common Stock
SEC:0001450485-26-000007·
€138,1534,500 shares@ €30.70070.0094% mcap50.0% of flow
Common Stock
SEC:0001450485-26-000007:0·
012,466 shares0
Common Stock
SEC:0001562180-22-002135:0·
013,717 shares0
Common Stock
SEC:0001562180-22-001757:0·
017,533 shares0
Common Stock
SEC:0001562180-22-001410·
017,533 shares0
Common Stock
SEC:0001562180-22-001410:0·
€176,09410,000 shares@ €17.60940.012% mcap100.0% of flow
Common Stock
SEC:0001562180-21-007116·
€176,09410,000 shares@ €17.60940.012% mcap50.0% of flow
Common Stock
SEC:0001562180-21-007116:0·
04,500 shares0
Common Stock
SEC:0001562180-21-004275·
04,500 shares0
Common Stock
SEC:0001562180-21-004275:0·
10 of 10 declarations
About Lurker Nancy
Nancy Lurker serves as President and CEO of EyePoint Pharmaceuticals, Inc. and Collegium Pharmaceutical, Inc. She leads these companies, overseeing their operations and developing strategies for growth. Her experience in the pharmaceutical sector is crucial for innovation and the development of new treatments.
